Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 58, Issue 6, Pages 1291-1294Publisher
OXFORD UNIV PRESS
DOI: 10.1093/jac/dkl401
Keywords
experimental meningitis; pneumococcal anti-serum; sepsis; outcome
Ask authors/readers for more resources
Objective: Bacteraemia concomitant with meningitis has been shown to greatly affect outcome. Consequently, the efficacy of serotype-specific anti-pneumococcal antiserum (APAS) was investigated in a rat model of pneumococcal meningitis. Methods: Rats were infected with Streptococcus pneumoniae serotype 3. All rats received ceftriaxone starting 26 h post-infection. APAS was administered either at the time of infection or 26 h post-infection and effects were compared with rats treated with antibiotics only. Results and conclusion: A significant clinical benefit was found when APAS was given at the time of infection whereas no effect was found when administered 26 h after infection. This work indicates that the clinical value of using APAS in pneumococcal meningitis may be limited.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available